- Home
- KYMR vs CLSK Comparison
KYMR vs CLSK Comparison
Compare KYMR & CLSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- CLSK
- Stock Information
- Founded
- KYMR 2015
- CLSK 1987
- Country
- KYMR United States
- CLSK United States
- Employees
- KYMR N/A
- CLSK N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- CLSK Finance: Consumer Services
- Sector
- KYMR Health Care
- CLSK Finance
- Exchange
- KYMR Nasdaq
- CLSK Nasdaq
- Market Cap
- KYMR 2.2B
- CLSK 1.9B
- IPO Year
- KYMR 2020
- CLSK N/A
- Fundamental
- Price
- KYMR $25.97
- CLSK $7.51
- Analyst Decision
- KYMR Buy
- CLSK Strong Buy
- Analyst Count
- KYMR 13
- CLSK 7
- Target Price
- KYMR $56.69
- CLSK $22.00
- AVG Volume (30 Days)
- KYMR 847.3K
- CLSK 27.2M
- Earning Date
- KYMR 05-01-2025
- CLSK 05-08-2025
- Dividend Yield
- KYMR N/A
- CLSK N/A
- EPS Growth
- KYMR N/A
- CLSK N/A
- EPS
- KYMR N/A
- CLSK 0.27
- Revenue
- KYMR $47,072,000.00
- CLSK $467,488,000.00
- Revenue This Year
- KYMR $16.24
- CLSK $118.59
- Revenue Next Year
- KYMR $22.41
- CLSK $36.65
- P/E Ratio
- KYMR N/A
- CLSK $27.49
- Revenue Growth
- KYMR N/A
- CLSK 118.07
- 52 Week Low
- KYMR $19.45
- CLSK $6.45
- 52 Week High
- KYMR $53.27
- CLSK $21.39
- Technical
- Relative Strength Index (RSI)
- KYMR 44.70
- CLSK 47.80
- Support Level
- KYMR $24.43
- CLSK $6.45
- Resistance Level
- KYMR $26.06
- CLSK $8.15
- Average True Range (ATR)
- KYMR 2.36
- CLSK 0.78
- MACD
- KYMR 0.41
- CLSK 0.06
- Stochastic Oscillator
- KYMR 70.12
- CLSK 62.49
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About CLSK CleanSpark Inc.
Cleanspark Inc is a bitcoin mining company. Through CleanSpark, Inc., and the Company's wholly owned subsidiaries, the company mines bitcoin. The company entered the bitcoin mining industry through its acquisition of ATL. Bitcoin mining is the sole reportable segment of the company.